Conversely, CD33 is present on AML cells especially in acute promyelocytic leukemia and in blasts harboring nucleophosmin1 (NPM1) or FLT3 internal tandem duplication (FLT3/ITD) mutations, and patients with increased CD33 levels experience shorter overall survival [59]. Here, CD33 is linked to acute myeloid leukemia.